EUVIMEDEUVIMED entdecken
Open Access

Paclitaxel, Epirubicin and Capecitabine (TEX) as First-Line Treatment for Metastatic Breast Cancer: A Pilot Phase I/II Feasibility Study

Z Einbeigi, D Bergström, T Hatschek, M Malmberg

Clinical medicine. Oncology · 2008

DOI: 10.4137/cmo.s1027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical medicine. Oncology, 2008. Verfasst von Z Einbeigi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Sahlgrenska University Hospital, Göteborg, Sweden. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thirteen patients with untreated metastatic breast cancer received epirubicin 60 mg/m 2 , paclitaxel 155 mg/m 2 (both day 1) and capecitabine 665 mg/m 2 twice daily (days 1-14) every 21 days, with intra-patient dose escalation/reduction. Grade 3/4 events were infrequent. Nine patients (69%) achieved an objective response. Median time to progression and overall survival were 6.6 and 23.5 months, respectively.

Schlagwörter

Stichwörter der Autor:innen

capecitabineepirubicinfirst-line chemotherapymetastatic breast cancerpaclitaxelphase I/II

Autor:innen und Institutionen

  • Department of Oncology, Sahlgrenska University Hospital, Göteborg, Sweden.

Zitieren

APA

Einbeigi, Z., Bergström, D., Hatschek, T., & Malmberg, M. (2008). Paclitaxel, Epirubicin and Capecitabine (TEX) as First-Line Treatment for Metastatic Breast Cancer: A Pilot Phase I/II Feasibility Study. Clinical medicine. Oncology. https://doi.org/10.4137/cmo.s1027

Vancouver

Einbeigi Z, Bergström D, Hatschek T, Malmberg M. Paclitaxel, Epirubicin and Capecitabine (TEX) as First-Line Treatment for Metastatic Breast Cancer: A Pilot Phase I/II Feasibility Study. Clinical medicine. Oncology. 2008. doi:10.4137/cmo.s1027

BibTeX
@article{Einbeigi2008,
  author = {Einbeigi, Z and Bergström, D and Hatschek, T and Malmberg, M},
  title = {Paclitaxel, Epirubicin and Capecitabine (TEX) as First-Line Treatment for Metastatic Breast Cancer: A Pilot Phase I/II Feasibility Study},
  journal = {Clinical medicine. Oncology},
  year = {2008},
  doi = {10.4137/cmo.s1027}
}
Kostenlos starten →